{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:34Z","timestamp":1792791454410,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Body-wide changes in bioenergetics, i.e., energy metabolism, occur in normal aging and disturbed bioenergetics may be an important contributing mechanism underlying late-onset Alzheimer\u2019s disease (LOAD). We investigated the bioenergetic profiles of fibroblasts from LOAD patients and healthy controls, as a function of age and disease. LOAD cells exhibited an impaired mitochondrial metabolic potential and an abnormal redox potential, associated with reduced nicotinamide adenine dinucleotide metabolism and altered citric acid cycle activity, but not with disease-specific changes in mitochondrial mass, production of reactive oxygen species, transmembrane instability, or DNA deletions. LOAD fibroblasts demonstrated a shift in energy production to glycolysis, despite an inability to increase glucose uptake in response to IGF-1. The increase of glycolysis and the abnormal mitochondrial metabolic potential in LOAD appeared to be inherent, as they were disease- and not age-specific. Our findings support the hypothesis that impairment in multiple interacting components of bioenergetic metabolism may be a key mechanism contributing to the risk and pathophysiology of LOAD.<\/jats:p>","DOI":"10.1038\/s41598-017-14420-x","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T10:34:41Z","timestamp":1508409281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Late-onset Alzheimer\u2019s disease is associated with inherent changes in bioenergetics profiles"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-8171","authenticated-orcid":false,"given":"Kai-C.","family":"Sonntag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-In","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher M.","family":"Amirault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"McPhie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Forester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"14420_CR1","doi-asserted-by":"publisher","first-page":"77sr71","DOI":"10.1126\/scitranslmed.3002369","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman, D. M., Morris, J. C. & Goate, A. M. Alzheimer\u2019s disease: the challenge of the second century. Science translational medicine \n                           3, 77sr71, https:\/\/doi.org\/10.1126\/scitranslmed.3002369 (2011).","journal-title":"Science translational medicine"},{"key":"14420_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbrc.2009.08.042","volume":"388","author":"SA Park","year":"2009","unstructured":"Park, S. A., Shaked, G. M., Bredesen, D. E. & Koo, E. H. Mechanism of cytotoxicity mediated by the C31 fragment of the amyloid precursor protein. Biochemical and biophysical research communications \n                           388, 450\u2013455, https:\/\/doi.org\/10.1016\/j.bbrc.2009.08.042 (2009).","journal-title":"Biochemical and biophysical research communications"},{"key":"14420_CR3","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega, K. G. et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science \n                           330, 1774, https:\/\/doi.org\/10.1126\/science.1197623 (2010).","journal-title":"Science"},{"key":"14420_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.bp.115.167569","volume":"208","author":"JR Harrison","year":"2016","unstructured":"Harrison, J. R. & Owen, M. J. Alzheimer\u2019s disease: the amyloid hypothesis on trial. Br J Psychiatry \n                           208, 1\u20133, https:\/\/doi.org\/10.1192\/bjp.bp.115.167569 (2016).","journal-title":"Br J Psychiatry"},{"key":"14420_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.arr.2015.09.003","volume":"25","author":"Z Amtul","year":"2016","unstructured":"Amtul, Z. Why therapies for Alzheimer\u2019s disease do not work: Do we have consensus over the path to follow? Ageing Res Rev \n                           25, 70\u201384, https:\/\/doi.org\/10.1016\/j.arr.2015.09.003 (2016).","journal-title":"Ageing Res Rev"},{"key":"14420_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","volume":"9","author":"D Krstic","year":"2013","unstructured":"Krstic, D. & Knuesel, I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol \n                           9, 25\u201334, https:\/\/doi.org\/10.1038\/nrneurol.2012.236 (2013).","journal-title":"Nat Rev Neurol"},{"key":"14420_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.molcel.2016.01.028","volume":"61","author":"N Sun","year":"2016","unstructured":"Sun, N., Youle, R. J. & Finkel, T. The Mitochondrial Basis of Aging. Mol Cell \n                           61, 654\u2013666, https:\/\/doi.org\/10.1016\/j.molcel.2016.01.028 (2016).","journal-title":"Mol Cell"},{"key":"14420_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/NEN.0000000000000091","volume":"73","author":"M Jove","year":"2014","unstructured":"Jove, M., Portero-Otin, M., Naudi, A. & Ferrer, I. & Pamplona, R. Metabolomics of human brain aging and age-related neurodegenerative diseases. J Neuropathol Exp Neurol \n                           73, 640\u2013657, https:\/\/doi.org\/10.1097\/NEN.0000000000000091 (2014).","journal-title":"J Neuropathol Exp Neurol"},{"key":"14420_CR9","doi-asserted-by":"publisher","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","volume":"8","author":"E Trushina","year":"2013","unstructured":"Trushina, E., Dutta, T., Persson, X. M., Mielke, M. M. & Petersen, R. C. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics. PLoS One \n                           8, e63644, https:\/\/doi.org\/10.1371\/journal.pone.0063644 (2013).","journal-title":"PLoS One"},{"key":"14420_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","volume":"77","author":"SM de la Monte","year":"2017","unstructured":"de la Monte, S. M. Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer\u2019s Disease. Drugs \n                           77, 47\u201365, https:\/\/doi.org\/10.1007\/s40265-016-0674-0 (2017).","journal-title":"Drugs"},{"key":"14420_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg, O., Wind, F. & Negelein, E. The Metabolism of Tumors in the Body. J Gen Physiol \n                           8, 519\u2013530 (1927).","journal-title":"J Gen Physiol"},{"key":"14420_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ncb1080","volume":"6","author":"A Almeida","year":"2004","unstructured":"Almeida, A., Moncada, S. & Bolanos, J. P. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol \n                           6, 45\u201351, https:\/\/doi.org\/10.1038\/ncb1080 (2004).","journal-title":"Nat Cell Biol"},{"key":"14420_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ncb1881","volume":"11","author":"A Herrero-Mendez","year":"2009","unstructured":"Herrero-Mendez, A. et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC\/C-Cdh1. Nat Cell Biol \n                           11, 747\u2013752, https:\/\/doi.org\/10.1038\/ncb1881 (2009).","journal-title":"Nat Cell Biol"},{"key":"14420_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10522-013-9479-7","volume":"14","author":"LA Demetrius","year":"2013","unstructured":"Demetrius, L. A. & Driver, J. Alzheimer\u2019s as a metabolic disease. Biogerontology \n                           14, 641\u2013649, https:\/\/doi.org\/10.1007\/s10522-013-9479-7 (2013).","journal-title":"Biogerontology"},{"key":"14420_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3389\/fphys.2014.00522","volume":"5","author":"LA Demetrius","year":"2014","unstructured":"Demetrius, L. A., Magistretti, P. J. & Pellerin, L. Alzheimer\u2019s disease: the amyloid hypothesis and the Inverse Warburg effect. Front Physiol \n                           5, 522, https:\/\/doi.org\/10.3389\/fphys.2014.00522 (2014).","journal-title":"Front Physiol"},{"key":"14420_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10522-012-9403-6","volume":"13","author":"LA Demetrius","year":"2012","unstructured":"Demetrius, L. A. & Simon, D. K. An inverse-Warburg effect and the origin of Alzheimer\u2019s disease. Biogerontology \n                           13, 583\u2013594, https:\/\/doi.org\/10.1007\/s10522-012-9403-6 (2012).","journal-title":"Biogerontology"},{"key":"14420_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger, M., Allaman, I. & Magistretti, P. J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab \n                           14, 724\u2013738, https:\/\/doi.org\/10.1016\/j.cmet.2011.08.016 (2011).","journal-title":"Cell Metab"},{"key":"14420_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10522-014-9525-0","volume":"15","author":"W Fu","year":"2014","unstructured":"Fu, W. & Jhamandas, J. H. Role of astrocytic glycolytic metabolism in Alzheimer\u2019s disease pathogenesis. Biogerontology \n                           15, 579\u2013586, https:\/\/doi.org\/10.1007\/s10522-014-9525-0 (2014).","journal-title":"Biogerontology"},{"key":"14420_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrn4019","volume":"16","author":"GJ Biessels","year":"2015","unstructured":"Biessels, G. J. & Reagan, L. P. Hippocampal insulin resistance and cognitive dysfunction. Nat Rev Neurosci \n                           16, 660\u2013671, https:\/\/doi.org\/10.1038\/nrn4019 (2015).","journal-title":"Nat Rev Neurosci"},{"key":"14420_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep03887","volume":"4","author":"NR Phillips","year":"2014","unstructured":"Phillips, N. R., Sprouse, M. L. & Roby, R. K. Simultaneous quantification of mitochondrial DNA copy number and deletion ratio: a multiplex real-time PCR assay. Sci Rep \n                           4, 3887, https:\/\/doi.org\/10.1038\/srep03887 (2014).","journal-title":"Sci Rep"},{"key":"14420_CR21","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1113\/jphysiol.2012.230185","volume":"590","author":"S Larsen","year":"2012","unstructured":"Larsen, S. et al. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol \n                           590, 3349\u20133360, https:\/\/doi.org\/10.1113\/jphysiol.2012.230185 (2012).","journal-title":"J Physiol"},{"key":"14420_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jalz.2013.04.508","volume":"10","author":"NR Phillips","year":"2014","unstructured":"Phillips, N. R., Simpkins, J. W. & Roby, R. K. Mitochondrial DNA deletions in Alzheimer\u2019s brains: a review. Alzheimers Dement \n                           10, 393\u2013400, https:\/\/doi.org\/10.1016\/j.jalz.2013.04.508 (2014).","journal-title":"Alzheimers Dement"},{"key":"14420_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0027-5107(02)00220-8","volume":"509","author":"BS Mandavilli","year":"2002","unstructured":"Mandavilli, B. S., Santos, J. H. & Van Houten, B. Mitochondrial DNA repair and aging. Mutat Res \n                           509, 127\u2013151 (2002).","journal-title":"Mutat Res"},{"key":"14420_CR24","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1089\/ars.2012.5039","volume":"18","author":"RX Santos","year":"2013","unstructured":"Santos, R. X. et al. Mitochondrial DNA oxidative damage and repair in aging and Alzheimer\u2019s disease. Antioxid Redox Signal \n                           18, 2444\u20132457, https:\/\/doi.org\/10.1089\/ars.2012.5039 (2013).","journal-title":"Antioxid Redox Signal"},{"key":"14420_CR25","doi-asserted-by":"publisher","first-page":"12504","DOI":"10.1074\/jbc.M114.618157","volume":"290","author":"W Fu","year":"2015","unstructured":"Fu, W., Shi, D., Westaway, D. & Jhamandas, J. H. Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity. J Biol Chem \n                           290, 12504\u201312513, https:\/\/doi.org\/10.1074\/jbc.M114.618157 (2015).","journal-title":"J Biol Chem"},{"key":"14420_CR26","doi-asserted-by":"publisher","first-page":"37245","DOI":"10.1074\/jbc.M112.366195","volume":"287","author":"JT Newington","year":"2012","unstructured":"Newington, J. T. et al. Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid beta and other toxins by decreasing mitochondrial respiration and reactive oxygen species production. J Biol Chem \n                           287, 37245\u201337258, https:\/\/doi.org\/10.1074\/jbc.M112.366195 (2012).","journal-title":"J Biol Chem"},{"key":"14420_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s007020050174","volume":"106","author":"M Bigl","year":"1999","unstructured":"Bigl, M., Bruckner, M. K., Arendt, T., Bigl, V. & Eschrich, K. Activities of key glycolytic enzymes in the brains of patients with Alzheimer\u2019s disease. J Neural Transm (Vienna) \n                           106, 499\u2013511, https:\/\/doi.org\/10.1007\/s007020050174 (1999).","journal-title":"J Neural Transm (Vienna)"},{"key":"14420_CR28","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin, E. NAD(+) in aging, metabolism, and neurodegeneration. Science \n                           350, 1208\u20131213, https:\/\/doi.org\/10.1126\/science.aac4854 (2015).","journal-title":"Science"},{"key":"14420_CR29","doi-asserted-by":"publisher","first-page":"e1002472","DOI":"10.1371\/journal.pbio.1002472","volume":"14","author":"YO Ali","year":"2016","unstructured":"Ali, Y. O. et al. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLoS Biol \n                           14, e1002472, https:\/\/doi.org\/10.1371\/journal.pbio.1002472 (2016).","journal-title":"PLoS Biol"},{"key":"14420_CR30","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s11064-016-2110-y","volume":"42","author":"H Jesko","year":"2017","unstructured":"Jesko, H., Wencel, P., Strosznajder, R. P. & Strosznajder, J. B. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders. Neurochem Res \n                           42, 876\u2013890, https:\/\/doi.org\/10.1007\/s11064-016-2110-y (2017).","journal-title":"Neurochem Res"},{"key":"14420_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","volume":"146-148","author":"S Martire","year":"2015","unstructured":"Martire, S., Mosca, L. & d\u2019Erme, M. PARP-1 involvement in neurodegeneration: A focus on Alzheimer\u2019s and Parkinson\u2019s diseases. Mech Ageing Dev \n                           146-148, 53\u201364, https:\/\/doi.org\/10.1016\/j.mad.2015.04.001 (2015).","journal-title":"Mech Ageing Dev"},{"key":"14420_CR32","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura, A. et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol \n                           60, 759\u2013767 (2001).","journal-title":"J Neuropathol Exp Neurol"},{"key":"14420_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola, C. Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat Rev Neurosci \n                           5, 347\u2013360, https:\/\/doi.org\/10.1038\/nrn1387 (2004).","journal-title":"Nat Rev Neurosci"},{"key":"14420_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","volume":"82","author":"LY Di Marco","year":"2015","unstructured":"Di Marco, L. Y. et al. Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease\u2013A review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiol Dis \n                           82, 593\u2013606, https:\/\/doi.org\/10.1016\/j.nbd.2015.08.014 (2015).","journal-title":"Neurobiol Dis"},{"key":"14420_CR35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/acel.12231","volume":"13","author":"K Popadin","year":"2014","unstructured":"Popadin, K., Safdar, A., Kraytsberg, Y. & Khrapko, K. When man got his mtDNA deletions? Aging Cell \n                           13, 579\u2013582, https:\/\/doi.org\/10.1111\/acel.12231 (2014).","journal-title":"Aging Cell"},{"key":"14420_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/10976649909080830","volume":"1","author":"AM Taylor","year":"1999","unstructured":"Taylor, A. M. et al. Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart. J Cardiovasc Magn Reson \n                           1, 23\u201332 (1999).","journal-title":"J Cardiovasc Magn Reson"},{"key":"14420_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3109\/10715762.2013.804622","volume":"47","author":"L Chico","year":"2013","unstructured":"Chico, L. et al. Oxidative stress and APO E polymorphisms in Alzheimer\u2019s disease and in mild cognitive impairment. Free Radic Res \n                           47, 569\u2013576, https:\/\/doi.org\/10.3109\/10715762.2013.804622 (2013).","journal-title":"Free Radic Res"},{"key":"14420_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JAD-2011-110710","volume":"27","author":"A Maruszak","year":"2011","unstructured":"Maruszak, A. et al. The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer\u2019s disease risk. J Alzheimers Dis \n                           27, 197\u2013210, https:\/\/doi.org\/10.3233\/JAD-2011-110710 (2011).","journal-title":"J Alzheimers Dis"},{"key":"14420_CR39","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.clinbiochem.2008.05.001","volume":"41","author":"H Kharrazi","year":"2008","unstructured":"Kharrazi, H. et al. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem \n                           41, 932\u2013936, https:\/\/doi.org\/10.1016\/j.clinbiochem.2008.05.001 (2008).","journal-title":"Clin Biochem"},{"key":"14420_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-016-0098-z","volume":"11","author":"S Sollvander","year":"2016","unstructured":"Sollvander, S. et al. Accumulation of amyloid-beta by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Mol Neurodegener \n                           11, 38, https:\/\/doi.org\/10.1186\/s13024-016-0098-z (2016).","journal-title":"Mol Neurodegener"},{"key":"14420_CR41","doi-asserted-by":"publisher","unstructured":"Batarseh, Y. S. et al. Amyloid-beta and Astrocytes Interplay in Amyloid-beta Related Disorders. Int J Mol Sci \n                           17, https:\/\/doi.org\/10.3390\/ijms17030338 (2016).","DOI":"10.3390\/ijms17030338"},{"key":"14420_CR42","doi-asserted-by":"publisher","unstructured":"Osborn, L. M., Kamphuis, W., Wadman, W. J. & Hol, E. M. Astrogliosis: An integral player in the pathogenesis of Alzheimer\u2019s disease. Prog Neurobiol, https:\/\/doi.org\/10.1016\/j.pneurobio.2016.01.001 (2016).","DOI":"10.1016\/j.pneurobio.2016.01.001"},{"issue":"Suppl 2","key":"14420_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/bjd.12365","volume":"169","author":"HA Rovito","year":"2013","unstructured":"Rovito, H. A. & Oblong, J. E. Nicotinamide preferentially protects glycolysis in dermal fibroblasts under oxidative stress conditions. Br J Dermatol \n                           169(Suppl 2), 15\u201324, https:\/\/doi.org\/10.1111\/bjd.12365 (2013).","journal-title":"Br J Dermatol"},{"key":"14420_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF03033501","volume":"13","author":"N Braidy","year":"2008","unstructured":"Braidy, N., Guillemin, G. & Grant, R. Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer\u2019s disease. Neurotox Res \n                           13, 173\u2013184 (2008).","journal-title":"Neurotox Res"},{"key":"14420_CR45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ana.410210507","volume":"21","author":"NR Sims","year":"1987","unstructured":"Sims, N. R., Finegan, J. M. & Blass, J. P. Altered metabolic properties of cultured skin fibroblasts in Alzheimer\u2019s disease. Ann Neurol \n                           21, 451\u2013457, https:\/\/doi.org\/10.1002\/ana.410210507 (1987).","journal-title":"Ann Neurol"},{"key":"14420_CR46","doi-asserted-by":"publisher","unstructured":"Kozlov, S., Afonin, A., Evsyukov, I. & Bondarenko, A. Alzheimer\u2019s disease: as it was in the beginning. Rev Neurosci, https:\/\/doi.org\/10.1515\/revneuro-2017-0006 (2017).","DOI":"10.1515\/revneuro-2017-0006"},{"key":"14420_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.292","volume":"5","author":"A Yalcin","year":"2014","unstructured":"Yalcin, A. et al. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death Dis \n                           5, e1337, https:\/\/doi.org\/10.1038\/cddis.2014.292 (2014).","journal-title":"Cell Death Dis"},{"key":"14420_CR48","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.neurobiolaging.2014.01.021","volume":"35","author":"W Kim","year":"2014","unstructured":"Kim, W. et al. miR-126 contributes to Parkinson\u2019s disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling. Neurobiol Aging \n                           35, 1712\u20131721, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.021 (2014).","journal-title":"Neurobiol Aging"},{"key":"14420_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12035-014-8989-x","volume":"53","author":"W Kim","year":"2016","unstructured":"Kim, W. et al. MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons. Mol Neurobiol \n                           53, 95\u2013108, https:\/\/doi.org\/10.1007\/s12035-014-8989-x (2016).","journal-title":"Mol Neurobiol"},{"key":"14420_CR50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0006-3495(88)83158-8","volume":"53","author":"B Ehrenberg","year":"1988","unstructured":"Ehrenberg, B., Montana, V., Wei, M. D., Wuskell, J. P. & Loew, L. M. Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys J \n                           53, 785\u2013794, https:\/\/doi.org\/10.1016\/S0006-3495(88)83158-8 (1988).","journal-title":"Biophys J"},{"key":"14420_CR51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods \n                           25, 402\u2013408, https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14420-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:34:46Z","timestamp":1671798886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14420-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14420"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14420-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]},"assertion":[{"value":"5 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14038"}}